کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2466379 | 1555332 | 2016 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs](/preview/png/2466379.png)
• Baculovirus-derived recombinant vaccines against influenza evaluated in swine.
• Vaccinated pigs development H1N1-specific HI antibody titers.
• Significant reduction in influenza-associated lung lesions after H1N1 challenge.
• Reduction in number of shedding pigs after H1N1 challenge.
The increasing diversity of influenza strains circulating in swine herds escalates the potential for the emergence of novel pandemic viruses and highlights the need for swift development of new vaccines. Baculovirus has proven to be a flexible platform for the generation of recombinant forms of hemagglutinin (HA) including subunit, VLP-displayed, and baculovirus-displayed antigens. These presentations have been shown to be efficacious in mouse, chicken, and ferret models but little is known about their immunogenicity in pigs. To assess the utility of these HA presentations in swine, Baculovirus constructs expressing HA fused to swine IgG2a Fc, displayed in a FeLV gag VLP, or displayed in the baculoviral envelope were generated. Vaccines formulated with these antigens wer The e administered to groups of pigs who were subsequently challenged with H1α cluster H1N1 swine influenza virus (SIV) A/Swine/Indiana/1726/88. Our results demonstrate that vaccination with any of these three vaccines elicits robust hemagglutinin inhibition titers in the serum and decreased the severity of SIV-associated lung lesions after challenge when compared to placebo-vaccinated controls. In addition, the number of pigs with virus detected in the lungs and nasal passages was reduced. Taken together, the results demonstrate that these recombinant approaches expressed with the baculovirus expression vector system may be viable options for development of SIV vaccines for swine.
Journal: Veterinary Microbiology - Volume 191, 15 August 2016, Pages 35–43